Tamara Lotan



Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tamara Lotan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer

Faisal, F. A., Murali, S., Kaur, H., Vidotto, T., Guedes, L. B., Salles, D. C., Kothari, V., Tosoian, J. J., Han, S., Hovelson, D. H., Hu, K., Spratt, D. E., Baras, A. S., Tomlins, S. A., Schaeffer, E. M. & Lotan, T. L., Jun 1 2020, In : Clinical Cancer Research. 26, 11, p. 2595-2602 8 p.

Research output: Contribution to journalArticle

Open Access
  • Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer

    Hashim, D., Gonzalez-Feliciano, A. G., Ahearn, T. U., Pettersson, A., Barber, L., Pernar, C. H., Ebot, E. M., Isikbay, M., Finn, S. P., Giovannucci, E. L., Lis, R. T., Loda, M., Parmigiani, G., Lotan, T., Kantoff, P. W., Mucci, L. A. & Graff, R. E., May 15 2020, In : International Journal of Cancer. 146, 10, p. 2694-2702 9 p.

    Research output: Contribution to journalArticle

  • Genomic and clinical characterization of stromal infiltration markers in prostate cancer

    Mahal, B. A., Alshalalfa, M., Zhao, S. G., Beltran, H., Chen, W. S., Chipidza, F., Davicioni, E., Karnes, R. J., Ku, S. Y., Lotan, T. L., Muralidhar, V., Rebbeck, T. R., Schaeffer, E. M., Spratt, D. E., Feng, F. Y. & Nguyen, P. L., Apr 1 2020, In : Cancer. 126, 7, p. 1407-1412 6 p.

    Research output: Contribution to journalArticle

  • Germline BLM mutations and metastatic prostate cancer

    Ledet, E. M., Antonarakis, E. S., Isaacs, W. B., Lotan, T. L., Pritchard, C. & Sartor, A. O., Feb 1 2020, In : Prostate. 80, 2, p. 235-237 3 p.

    Research output: Contribution to journalArticle

  • High extratumoral mast cell counts are associated with a higher risk of adverse prostate cancer outcomes

    Sullivan, H. H., Heaphy, C. M., Kulac, I., Cuka, N., Lu, J., Barber, J. R., de Marzo, A. M., Lotan, T. L., Joshu, C. E. & Sfanos, K. S., Jan 1 2020, In : Cancer Epidemiology Biomarkers and Prevention. 29, 3, p. 668-675 8 p.

    Research output: Contribution to journalArticle